Eighty per cent of the cases of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) have an infective aetiology, atypical bacteria including Mycoplasma pneumoniae accounting for 5–10 % of these. However, the importance of association of M. pneumoniae with episodes of AECOPD still remains doubtful. The present study was therefore undertaken to delineate the extent of involvement of M. pneumoniae in patients with AECOPD at a referral hospital in Delhi, India. Sputum samples and throat swabs from a total of 100 AECOPD patients attending the Clinical Research Center of Vallabhbhai Patel Chest Institute, Delhi, were collected during a 2-year period (January 2004–June 2006). The samples were investigated for the presence of aerobic bacterial pathogens and M. pneumoniae. Diagnosis of infection with M. pneumoniae was based on culture, serology, direct detection of M. pneumoniae specific antigen and PCR. Bacterial aetiology could be established in 16 of the 100 samples studied. Pseudomonas spp. were recovered from eight cases, Streptococcus pneumoniae from four and Klebsiella spp. from two cases. Acinetobacter sp. and Moraxella catarrhalis were isolated from one case each. Serological evidence of M. pneumoniae infection and/or detection of M. pneumoniae specific antigen were seen in 16 % of the cases. One case with definite evidence of M. pneumoniae infection also had coinfection with Pseudomonas spp. However, no direct evidence of M. pneumoniae infection was found in our study population as defined by culture isolation or PCR. In conclusion, although the serological prevalence of M. pneumoniae infection in our study population was significantly higher than in the control group, there was no direct evidence of it playing a role in AECOPD.
American Thoracic Society.1995; Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 152:S77–S121
BarkerC. E.,
SillisM.,
WreghittT. G.1990; Evaluation of Serodia Myco II particle agglutination test for detecting Mycoplasma pneumoniae antibody: comparison with μ-capture ELISA and indirect immunofluorescence. J Clin Pathol 43:163–165[CrossRef]
ColleeJ. G.,
MilesR. S.1989; Tests for identification of bacteria. In Mackie and McCartney's Practical Medical Microbiology , 13th edn. pp 141–160 Edited by
ColleeJ. G.,
DuguidJ. P.,
FraserA. G.,
MarmionB. P.
Edinburgh: Churchill Livingstone;
DiederenB. M.,
van der ValkP. D.,
KluytmansJ. A.,
PeetersM. F.,
HendrixR.2007; The role of atypical respiratory pathogens in exacerbations of chronic obstructive pulmonary disease. Eur Respir J 30:240–244[CrossRef]
GohS. K.,
JohanA.,
CheongT. H.,
WangY. T.1999; A prospective study of infections with atypical pneumonia organisms in acute exacerbations of chronic bronchitis. Ann Acad Med Singapore 28:476–480
GumpD. W.,
PhillipsC. A.,
ForsythB. R.,
McIntoshK.,
LambornK. R.,
StouchW. H.1976; Role of infection in chronic bronchitis. Am Rev Respir Dis 113:465–474
HiraiY.,
ShiodeJ.,
MasayoshiT.,
KanemasaY.1991; Application of an indirect immunofluorescence test for detection of Mycoplasma pneumoniae in respiratory exudates. J Clin Microbiol 29:2007–2012
LiebermanD.,
LiebermanD.,
PrintzS.,
Ben-YaakovM.,
LazarovichZ.,
OhanaB.,
FriedmanM. G.,
DvoskinB.,
LeinonenM.,
BoldurI.2003; Atypical pathogen infection in adults with acute exacerbation of bronchial asthma. Am J Respir Crit Care Med 167:406–410[CrossRef]
ParkS. J.,
LeeY. C.,
RheeY. K.,
LeeH. B.2005; Seroprevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in stable asthma and chronic obstructive pulmonary disease. J Korean Med Sci 20:225–228[CrossRef]
RamirezJ. A.,
AhkeeS.,
TolentinoA.,
MillerR. D.,
SummersgillJ. T.1996; Diagnosis of Legionella pneumophila , Mycoplasma pneumoniae or Chlamydia pneumoniae lower respiratory infection using the polymerase chain reaction on a single throat swab specimen. Diagn Microbiol Infect Dis 24:7–14[CrossRef]
SmithC. B.,
GoldenC. A.,
KannerR. E.,
RenzettiA. D.Jr1980; Association of viral and Mycoplasma pneumoniae infections with acute respiratory illness in patients with chronic obstructive pulmonary diseases. Am Rev Respir Dis 121:225–232
SolerN.,
TorresA.,
EwigS.,
GonzalezJ.,
CelisR.,
El-EbiaryM.,
HernandezC.,
Rodriguez-RoisinR.1998; Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med 157:1498–1505[CrossRef]
UldumS. A.,
JensenJ. S.,
Sondergard-AndersenJ.,
LindK.1992; Enzyme immunoassay for detection of immunoglobulin M (IgM) and IgG antibodies to Mycoplasma pneumoniae
. J Clin Microbiol 30:1198–1204